pH-controlled drug loading and release from biodegradable microcapsules.
Microcapsules made of biopolymers are of both scientific and technological interest and have many potential applications in medicine, including their use as controlled drug delivery devices. The present study makes use of the electrostatic interaction between polycations and polyanions to form a multilayered microcapsule shell and also to control the loading and release of charged drug molecules inside the microcapsule. Micron-sized calcium carbonate (CaCO3) particles were synthesized and integrated with chondroitin sulfate (CS) through a reaction between sodium carbonate and calcium nitrate tetrahydrate solutions suspended with CS macromolecules. Oppositely charged biopolymers were alternately deposited onto the synthesized particles using electrostatic layer-by-layer self-assembly, and glutaraldehyde was introduced to cross-link the multilayered shell structure. Microcapsules integrated with CS inside the multilayered shells were obtained after decomposition of the CaCO3 templates. The integration of a matrix (i.e., CS) permitted the subsequent selective control of drug loading and release. The CS-integrated microcapsules were loaded with a model drug, bovine serum albumin labeled with fluorescein isothiocyanate (FITC-BSA), and it was shown that pH was an effective means of controlling the loading and release of FITC-BSA. Such CS-integrated microcapsules may be used for controlled localized drug delivery as biodegradable devices, which have advantages in reducing systemic side effects and increasing drug efficacy.
Zhao
Qinghe
Q
Department of Orthopaedics, School of Medicine, West Virginia University, Morgantown, West Virginia 26506-9196, USA.
Li
Bingyun
B
D002119:Calcium Carbonate / Q000737:chemistry; D002214:Capsules / Q000008:administration & dosage* / Q000737:chemistry / Q000493:pharmacokinetics; D002809:Chondroitin Sulfates / Q000737:chemistry; D016503:Drug Delivery Systems / Q000379:methods*; D016650:Fluorescein-5-isothiocyanate / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000737:chemistry / Q000493:pharmacokinetics; D006863:Hydrogen-Ion Concentration; D008855:Microscopy, Electron, Scanning; D012710:Serum Albumin, Bovine / Q000008:administration & dosage / Q000737:chemistry / Q000493:pharmacokinetics
D002214:Capsules; C039217:fluorescein isothiocyanate bovine serum albumin; D012710:Serum Albumin, Bovine; D002809:Chondroitin Sulfates; D002119:Calcium Carbonate; D016650:Fluorescein-5-isothiocyanate